CBLL Wins FDA Breakthrough Status for AI-Based LVO Stroke Detection

Key Takeaways Ceribell received FDA Breakthrough Device Designation for its AI-based LVO stroke detection solution.CBLL is extending its point-of-care EEG platform beyond seizures and delirium into time-sensitive stroke care.The designation supports faster FDA interactions and earlier commercialization, boosting CBLL's visibility.CeriBell Inc. (CBLL) recently announced that the FDA has granted Breakthrough Device Designation for its Large Vessel Occlusion (LVO) stroke detection and monitoring solution desig ...